Keyphrases
Receptor-mediated
100%
Androgen Receptor
100%
Prostate Epithelial Cells
100%
Growth Suppression
100%
Mediated Growth
100%
Lentis
100%
Cyclin-dependent Kinase 4 (CDK4)
33%
CDKN1A
26%
Androgens
20%
Dihydrotestosterone
20%
Overexpression
13%
Cell Cycle Progression
13%
Cyclin D1 (CCND1)
13%
Cyclin D
13%
Multiple Mechanisms
6%
Prostate Gland
6%
Homeostasis
6%
Growth Differentiation
6%
Cell Cycle Arrest
6%
Transcriptional Repression
6%
Transcriptional Activation
6%
Epithelial Cell Line
6%
Cyclin-dependent Kinase Inhibitor
6%
Life Cycle Analysis
6%
Developmental Effects
6%
Physiological Effects
6%
Prostate Development
6%
Cyclin D2 (CCND2)
6%
Cyclin-dependent Kinase
6%
Luminal Cell
6%
G1-S Transition
6%
Androgen-responsive Gene
6%
Epithelial Cell Proliferation
6%
MRNA Decay
6%
Prostate Neoplasms
6%
Pathologic Effects
6%
Biochemistry, Genetics and Molecular Biology
Androgen Receptor
100%
Growth Inhibition
100%
Messenger RNA
20%
Cell Cycle Progression
13%
Downregulation
13%
Cyclin D1
13%
Cyclin D
13%
Homeostasis
6%
Cell Proliferation
6%
Transcription Initiation
6%
Upregulation
6%
Cell Cycle
6%
Cell Cycle Arrest
6%
Cyclin-Dependent Kinase
6%
Cell-Cycle Analysis
6%
S Phase
6%
Cyclin D2
6%
Cyclin-Dependent Kinase Complex
6%
Neuroscience
Androgen Receptor
100%
Epithelial Cells
100%
Androgen
26%
Dihydrotestosterone
20%
Cell Cycle
13%
Cyclin-Dependent Kinase
13%
Cell Cycle Progression
13%
Cyclin D1
13%
Cyclin D
13%
Cell Proliferation
6%
Cell Line
6%
Transcription Initiation
6%
Cell Cycle Arrest
6%
Cyclin D2
6%
Pharmacology, Toxicology and Pharmaceutical Science
Androgen Receptor
100%
Androgen
26%
Androstanolone
20%
Cyclin D1
13%
Cyclin D
13%
Neoplasm
6%
Cyclin Dependent Kinase Inhibitor
6%
Cyclin Dependent Kinase
6%
Cyclin D2
6%